S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Avid Bioservices (CDMO) Earnings Date, Estimates & Call Transcripts

$6.52
-0.19 (-2.83%)
(As of 04/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Apr. 22Estimated
Actual EPS
(Apr. 18)
-$0.05 Missed By -$0.05
Skip Charts & View Estimated and Actual Earnings Data

CDMO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CDMO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avid Bioservices Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($0.04)($0.04)($0.04) 
Q2 20241($0.07)($0.07)($0.07) 
Q3 20241$0.01$0.01$0.01 
Q4 20241$0.03$0.03$0.03 
FY 20244($0.07)($0.07) ($0.07)

CDMO Earnings Date and Information

Avid Bioservices last posted its quarterly earnings data on April 18th, 2024. The biopharmaceutical company reported ($0.05) EPS for the quarter. Avid Bioservices has generated ($0.17) earnings per share over the last year (($0.17) diluted earnings per share). Avid Bioservices has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 22nd, 2024 based off prior year's report dates.

Avid Bioservices Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/22/2024
Estimated)
------- 
4/18/2024--($0.05)($0.05)---
12/7/2023Q2 2024($0.12)($0.15)($0.03)($0.15)$33.55 million$25.40 million
9/7/2023Q1 2024($0.04)($0.03)+$0.01($0.03)$34.00 million$37.73 million    
6/21/2023Q2 2023($0.02)$0.05+$0.07-$39.00 million$39.80 million    
3/13/2023Q3 2023($0.08)$0.03+$0.11$0.05$36.00 million$38.02 million
12/6/2022Q2 2023($0.05)($0.04)+$0.01($0.06)$31.00 million$34.76 million    
9/6/2022Q1 2023$0.03$0.02($0.01)$0.02$34.00 million$36.69 million
6/29/2022Q4 2022($0.02)$0.04+$0.06($1.57)$29.20 million$31.23 million
3/8/2022Q3 2022$0.05$0.06+$0.01$0.08$28.00 million$31.51 million    
12/7/2021Q4 2021$0.02$0.06+$0.04$0.08$25.00 million$26.11 million    
9/7/2021Q3 2021$0.04$0.10+$0.06$0.10$25.00 million$30.75 million    
6/28/2021Q2 2021$0.01($0.04)($0.05)($0.04)$20.70 million$27.61 million    

Avid Bioservices Earnings - Frequently Asked Questions

When is Avid Bioservices's earnings date?

Avid Bioservices has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 22nd, 2024 based off last year's report dates. Learn more on CDMO's earnings history.

How much revenue does Avid Bioservices generate each year?

Avid Bioservices (NASDAQ:CDMO) has a recorded annual revenue of $149.27 million.

How much profit does Avid Bioservices generate each year?

Avid Bioservices (NASDAQ:CDMO) has a recorded net income of $560,000.00. CDMO has generated -$0.17 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:CDMO) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners